3 research outputs found

    Condition Monitoring System of Wind Turbine Generators

    Get PDF
    The development and implementation of the condition monitoring systems (CMS) play a significant role in overcoming the number of failures in the wind turbine generators that result from the harsh operation conditions, such as over temperature, particularly when turbines are deployed offshore. In order to increase the reliability of the wind energy industry, monitoring the operation conditions of wind generators is essential to detect the immediate faults rapidly and perform appropriate preventative maintenance. CMS helps to avoid failures, decrease the potential shutdowns while running, reduce the maintenance and operation costs and maintain wind turbines protected. The knowledge of wind turbine generators\u27 faults, such as stator and rotor inter-turn faults, is indispensable to perform the condition monitoring accurately, and assist with maintenance decision making. Many techniques are utilized to avoid the occurrence of failures in wind turbine generators. The majority of the previous techniques that are applied to monitor the wind generator conditions are based on electrical and mechanical concepts and theories. An advanced CMS can be implemented by using a variety of different techniques and methods to confirm the validity of the obtained electrical and mechanical condition monitoring algorithms. This thesis is focused on applying CMS on wind generators due to high temperature by contributing the statistical, thermal, mathematical, and reliability analyses, and mechanical concepts with the electrical methodology, instead of analyzing the electrical signal and frequencies trends only. The newly developed algorithms can be compared with previous condition monitoring methods, which use the electrical approach in order to establish their advantages and limitations. For example, the hazard reliability techniques of wind generators based on CMS are applied to develop a proper maintenance strategy, which aims to extend the system life-time and reduce the potential failures during operation due to high generator temperatures. In addition, the use of some advanced statistical techniques, such as regression models, is proposed to perform a CMS on wind generators. Further, the mechanical and thermal characteristics are employed to diagnose the faults that can occur in wind generators. The rate of change in the generator temperature with respect to the induced electrical torque; for instance is considered as an indicator to the occurrence of faults in the generators. The behavior of the driving torque of the rotating permanent magnet with respect to the permanent magnet temperature can also utilize to indicate the operation condition. The permanent magnet model describes the rotating permanent magnet condition during operation in the normal and abnormal situations. In this context, a set of partial differential equations is devolved for the characterization of the rotations of the permanent. Finally, heat transfer analysis and fluid mechanics methods are employed to develop a suitable CMS on the wind generators by analyzing the operation conditions of the generator\u27s heat exchanger. The proposed methods applied based on real data of different wind turbines, and the obtained results were very convincing

    Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    Get PDF
    SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication

    Proceedings of First Conference for Engineering Sciences and Technology: Vol. 2

    No full text
    This volume contains contributed articles of Track 4, Track 5 & Track 6, presented in the conference CEST-2018, organized by Faculty of Engineering Garaboulli, and Faculty of Engineering, Al-khoms, Elmergib University (Libya) on 25-27 September 2018. Track 4: Industrial, Structural Technologies and Science Material Track 5: Engineering Systems and Sustainable Development Track 6: Engineering Management Other articles of Track 1, 2 & 3 have been published in volume 1 of the proceedings at this lin
    corecore